Michael Khan Selected Research

Michael Khan Research Topics

9	Neoplasms (Cancer) 06/2023 - 12/2004
3	Head and Neck Neoplasms (Head and Neck Cancer) 10/2023 - 10/2022
2	Stomatitis 10/2023 - 03/2023
2	Inflammation (Inflammations) 06/2023 - 11/2003
2	Cognitive Dysfunction 01/2023 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2020
1	Weight Loss (Weight Reduction) 10/2023
1	Squamous Cell Carcinoma of Head and Neck 03/2023
1	Overweight 01/2023
1	Anemia 10/2022
1	Liver Diseases (Liver Disease) 01/2020
1	Atherosclerosis 01/2020
1	Glucose Intolerance 06/2015
1	Body Weight (Weight, Body) 06/2015
1	Neoplasm Metastasis (Metastasis) 12/2014
1	Hyperglycemia 07/2008
1	Carcinogenesis 05/2002

5	Proteins (Proteins, Gene)FDA Link 02/2014 - 05/2002
3	Biomarkers (Surrogate Marker)IBA 06/2023 - 05/2006
2	Opiate AlkaloidsIBA 10/2023 - 03/2023
1	Gabapentin (Neurontin)FDA LinkGeneric 03/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Amyloid beta-PeptidesIBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 10/2022
1	LipidsIBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Insulin (Novolin)FDA Link 06/2015
1	Therapeutic UsesIBA 12/2014
1	Atu027IBA 12/2014
1	preproinsulinIBA 07/2008
1	Lipoproteins (Lipoprotein)IBA 11/2003

2	Radiotherapy 10/2023 - 03/2023
2	Therapeutics 11/2006 - 12/2004
1	Enteral Nutrition (Feeding, Tube) 10/2023
1	Chemoradiotherapy 01/2023
1	Aftercare (After-Treatment) 01/2023
1	Combined Modality Therapy 01/2023
1	Premedication 12/2014
1	Intravenous Infusions 12/2014